LIPOPROTEIN(A) SERUM LEVELS AND APOLIPOPROTEIN(A) PHENOTYPES IN CHILDREN WITH CHRONIC RENAL-DISEASE

被引:37
|
作者
QUERFELD, U
LANG, M
FRIEDRICH, JB
KOHL, B
FIEHN, W
SCHARER, K
机构
[1] IMMUNO AG, RES DEPT, HEIDELBERG, GERMANY
[2] UNIV HEIDELBERG, DEPT PEDIAT, W-6900 HEIDELBERG, GERMANY
[3] UNIV HEIDELBERG, DEPT INTERNAL MED, W-6900 HEIDELBERG, GERMANY
关键词
D O I
10.1203/00006450-199312000-00015
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Lipoprotein(a) [Lp(a)] has recently been characterized as a genetically determined risk factor for atherosclerosis and thrombosis. Normally, Lp(a) serum levels are closely related to the apo(a) phenotype. We studied Lp(a) serum levels and apo(a) phenotypes in 136 young subjects, aged 0.8-24.7 y, including patients with glomerular disease and normal renal function (n = 28), patients with chronic renal failure (n = 20), patients treated by hemodialysis (n = 10), peritoneal dialysis (n = 16), and renal transplantation (n = 23), and in controls (n = 39). Of all, 21 patients had proteinuria in the nephrotic range. The distribution of Lp(a) levels in normal subjects was skewed to the left with 97% having levels below 300 mg/L. A subpopulation with increased Lp(a) levels (13-42%) could be detected in all groups with renal disease, and increased mean serum Lp(a) levels were found in patients with nephrotic range proteinuria, in patients with chronic renal failure, and in patients on peritoneal dialysis. Serum Lp(a) levels were not correlated with age, gender, type of renal disease, renal function or severity of proteinuria, but were correlated with the apo(a) phenotype. For a given phenotype, Lp(a) levels tended to be higher in patients than in controls. We conclude that increased Lp(a) serum levels are frequently found in young patients with chronic renal disease, possibly predisposing them to an increased risk for atherosclerosis and thrombosis.
引用
收藏
页码:772 / 776
页数:5
相关论文
共 50 条
  • [1] APOLIPOPROTEIN-A AND APOLIPOPROTEIN-B LEVELS IN CHRONIC RENAL-DISEASE
    SAVDIE, E
    GIBSON, JC
    STEWART, JH
    SIMONS, LA
    MAHONY, JF
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1978, 8 (02): : 240 - 240
  • [2] SERUM VANADIUM LEVELS IN CHRONIC RENAL-DISEASE
    BELLOREUSS, EN
    GRADY, TP
    MAZUMDAR, DC
    [J]. ANNALS OF INTERNAL MEDICINE, 1979, 91 (05) : 743 - 743
  • [3] LIPOPROTEIN(A) LEVELS IN CHRONIC RENAL-DISEASE STATES, DIALYSIS AND TRANSPLANTATION
    IRISH, AB
    SIMONS, LA
    SAVDIE, E
    HAYES, JM
    SIMONS, J
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1992, 22 (03): : 243 - 248
  • [4] SERUM LIPOPROTEIN ALTERATIONS IN RENAL-DISEASE
    MORDASINI, R
    RIESEN, W
    [J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1982, 112 (39) : 1335 - 1340
  • [5] LIPOPROTEIN(A) AND TREATMENT OF CHRONIC RENAL-DISEASE
    BUGGY, D
    BREATHNACH, A
    KEOGH, B
    COOKE, T
    FEELY, J
    [J]. JOURNAL OF INTERNAL MEDICINE, 1993, 234 (05) : 453 - 455
  • [6] PLASMA APOLIPOPROTEIN AIV LEVELS AND LIPOPROTEIN DISTRIBUTION IN END-STAGE RENAL-DISEASE
    DIEPLINGER, H
    KONIG, P
    GRAF, H
    ROSSENEU, M
    UTERMANN, G
    [J]. BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1988, 369 (09): : 807 - 807
  • [7] CHRONIC RENAL-DISEASE IN CHILDREN
    TOPOR, M
    [J]. NURSING CLINICS OF NORTH AMERICA, 1981, 16 (03) : 587 - 597
  • [8] SERUM C-PEPTIDE LEVELS IN PATIENTS WITH CHRONIC RENAL-DISEASE
    RAMIREZ, G
    ONEILL, WM
    BLOOMER, HA
    JUBIZ, W
    [J]. CLINICAL RESEARCH, 1978, 26 (02): : A130 - A130
  • [9] CALCITONIN LEVELS IN CHRONIC RENAL-DISEASE
    SILVA, OL
    BECKER, KL
    SHALHOUB, RJ
    SNIDER, RH
    BIVINS, LE
    MOORE, CF
    [J]. NEPHRON, 1977, 19 (01): : 12 - 18
  • [10] Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure
    Kronenberg, F
    Kuen, E
    Ritz, E
    Junker, E
    König, P
    Kraatz, G
    Lhotta, K
    Mann, JFE
    Müller, GA
    Neyer, U
    Riegel, W
    Riegler, P
    Schwenger, V
    Von Eckardstein, A
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2000, 11 (01): : 105 - 115